Clinical Trial Update: Vitreous Level Of Tumor Necrosis Factor Alpha In Patients With Retinal Vein Occlusion

View source ↗

Summary

This ClinicalTrials.gov entry reports on a completed study measuring vitreous levels of tumor necrosis factor-alpha in patients with retinal vein occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Vein Occlusion

Snippet

Sponsor: Kasr El Aini Hospital | Conditions: Retinal Vein Occlusion | Status: COMPLETED